ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

September 23, 2005

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

Program Announcements Non-Invasive Detection Of Lung Cancer

April 15, 1983

FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure.

February 1, 2002

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999